Karen L. Zaderej's Net Worth

$15.4 Million

Estimate Recalculated Sep 17, 2024 08:17PM EST

Who is Karen L. Zaderej

Karen L. Zaderej has an estimated net worth of $15.4 Million. This is based on reported shares across multiple companies, which include Axogen, Inc., VIVEVE MEDICAL, INC., and EyePoint Pharmaceuticals, Inc..

SEC CIK

Karen L. Zaderej's CIK is 0001530968

Past Insider Trading and Trends

2021 was Karen L. Zaderej's most active year for acquiring shares with 13 total transactions. Karen L. Zaderej's most active month to acquire stocks was the month of November. 2021 was Karen L. Zaderej's most active year for disposing of shares, totalling 19 transactions. Karen L. Zaderej's most active month to dispose stocks was the month of November. 2019 saw Karen L. Zaderej paying a total of $1,298,683.67 for 115,321 shares, this is the most they've acquired in one year. In 2021 Karen L. Zaderej cashed out on 449,647 shares for a total of $4,097,528.49, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Axogen, Inc.

CEO
Updated Mar 25, 2024
Form 4
-3.07%
-39.28K
$7.68
-$301.67K
Mar 25, 2024
1.24M
Sale
Mar 16 - Mar 21
Form 4
2.10%
22.08K
Oct 13, 2023
1.07M
Grant
Jul 18
Form 4
26.73%
291.00K
Mar 20, 2023
1.38M
Options
Mar 16
Form 4
0.88%
8.80K
Dec 29, 2022
1.01M
Options
Dec 27
Form 4
$5.09
$136.14K
Dec 16, 2022
1.01M
Options
Dec 15
Form 4
0.66%
12.99K
$8.40
-$76.28K
Jul 20, 2022
1.97M
Acquisition
Jul 18 - Jul 19
Form 4
49.07%
486.88K
Mar 18, 2022
1.48M
Options
Mar 16
Form 4
1.51%
13.98K
Feb 17, 2022
940.38K
Grant
Feb 15
Form 4
-0.19%
-1.75K
$9.74
-$17.06K
Dec 29, 2021
930.08K
Options
Dec 27
Form 4
-0.13%
-1.24K
$9.24
-$11.49K
Dec 22, 2021
923.03K
Options
Dec 20
Form 4
$8.95
Nov 29, 2021
1.08M
Options
Nov 24
Form 4
$4.13
Aug 16, 2021
895.52K
Options
Aug 12 - Aug 13
Form 4
-4.61%
-41.00K
$8.43
-$757.19K
Aug 10, 2021
849.02K
Sale
ScheduledAug 06 - Aug 10
Form 4
1.73%
13.27K
$19.20
-$169.19K
Jul 21, 2021
780.02K
Grant
Jul 19 - Jul 20
Form 4
$5.09
Apr 20, 2021
875.91K
Options
Apr 16
Form 4
$3.67
Mar 29, 2021
665.91K
Options
Mar 25
Form 4
126.60K
Mar 18, 2021
126.60K
Grant
Mar 16
Form 4
3.66%
22.31K
$18.71
-$143.81K
Feb 18, 2021
631.41K
Grant
Feb 16 - Feb 17
Form 4
-9.64%
-65.00K
$20.00
-$1.30M
Jan 12, 2021
609.10K
Sale
ScheduledJan 08
Form 4
0.79%
5.30K
$17.81
-$62.33K
Dec 30, 2020
674.10K
Grant
Dec 27 - Dec 29
Form 4
$4.81
$93.19K
Dec 28, 2020
666.09K
Options
Dec 23
Form 4
0.29%
1.85K
$16.42
-$20.94K
Dec 22, 2020
646.72K
Grant
Dec 18 - Dec 21
Form 4
-2.12%
-14.00K
$14.53
-$203.42K
Nov 10, 2020
644.87K
Sale
ScheduledNov 09
Form 4
3.66%
23.25K
$4.81
$55.92K
Apr 20, 2020
658.87K
Options
Apr 16
Form 4
132.10K
Mar 18, 2020
132.10K
Grant
Mar 16
Form 4
3.94%
24.56K
$14.68
-$79.70K
Feb 20, 2020
647.24K
Grant
Feb 18
Form 4
5.04%
29.89K
$17.34
-$175.34K
Jan 17, 2020
622.68K
Acquisition
Jan 01
Form 4
1.05%
6.25K
Dec 20, 2019
599.53K
Grant
Dec 18
Form 4
14.47%
75.00K
$13.50
$1.01M
Aug 12, 2019
593.28K
Purchase
Aug 09
Form 4
$0.27
$4.88K
May 31, 2019
510.28K
Options
May 29
Form 4
3.36%
16.02K
$17.57
$281.38K
Feb 19, 2019
492.22K
Grant
Feb 15
Form 4
77.30K
Dec 31, 2018
77.30K
Grant
Dec 27
Form 4
$2.74
$82.20K
Dec 21, 2018
476.21K
Options
Nov 19 - Dec 19
Form 4
-1.49%
-6.76K
$15.56
-$9.57
Nov 21, 2018
446.21K
Options
Nov 19
Form 4
-6.13%
-25.00K
$33.18
-$829.62K
Nov 15, 2018
382.97K
Sale
Nov 13 - Nov 14
Form 4
-2.41%
-10.06K
$39.30
-$395.36K
Aug 09, 2018
407.97K
Tax
Aug 07
Form 4
$2.74
$479.50K
Aug 06, 2018
518.03K
Options
Aug 02
Form 4
87.50K
Dec 20, 2017
87.50K
Grant
Dec 18
Form 4
103.04%
249.50K
Jan 03, 2017
491.65K
Grant
Dec 29
Form 4
4.31%
10.00K
$7.50
$75.00K
Oct 14, 2016
242.15K
Purchase
Oct 07
Form 4/A
210.00K
May 31, 2016
210.00K
Grant
Dec 28
Form 4
210.00K
Dec 30, 2015
210.00K
Grant
Dec 28
Form 4
1.45%
3.33K
$3.16
$10.49K
May 29, 2015
232.15K
Purchase
May 27
Form 4
4.38%
9.60K
$2.75
$26.40K
Feb 12, 2015
228.82K
Grant
Feb 10
Form 4
25.00%
81.00K
Dec 31, 2014
405.06K
Grant
Dec 29
Form 4
1.52%
5.00K
$2.43
$12.15K
Jun 04, 2014
334.06K
Purchase
Jun 03
Form 4
1.54%
5.00K
$2.70
$13.50K
May 13, 2014
329.06K
Purchase
May 12
Form 4
22.88%
146.20K
$0.34
$24.77K
Mar 17, 2014
785.11K
Purchase
Mar 13 - Mar 14
Form 4
7.53%
37.25K
Jan 06, 2014
531.78K
Grant
Jan 02
Form 4
6.90%
8.33K
$3.00
$25.00K
Aug 15, 2013
129.12K
Purchase
Aug 14
Form 4
0.75%
900.00
$2.50
$2.25K
Dec 13, 2012
120.79K
Purchase
Dec 10
Form 4
0.08%
100.00
$2.69
$269.00
Nov 23, 2012
119.89K
Purchase
Nov 20
Form 3/A
Mar 22, 2012
Form 4
375.00K
Dec 28, 2011
375.00K
Grant
Dec 26
Form 4
$0.27
$20.72K
Dec 21, 2011
209.92K
Options
Dec 19
Form 3
Oct 11, 2011
43.05K
Showing 56 results

VIVEVE MEDICAL, INC.

Investor
Updated Sep 13, 2018
Form 3
Sep 13, 2018
Showing 1 results

EyePoint Pharmaceuticals, Inc.

Investor
Updated Jul 12, 2024
Form 4
Jul 12, 2024
6.00K
Options
Jul 11
Form 4
25.01K
Jan 09, 2024
25.01K
Grant
Jan 05
Form 4
Jul 12, 2023
6.00K
Options
Jul 11
Form 4
39.10K
Jun 22, 2023
39.10K
Grant
Jun 20
Form 4
28.00K
Jul 13, 2022
28.00K
Grant
Jul 11
Form 3
Jul 13, 2022
Showing 6 results